Healthcare / Pharmaceutical RetailersUpdated 2026-05-10 22:07 UTC

NSE/MEDPLUS stock hub

NSE/MEDPLUS has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

NSE/MEDPLUSis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

105B

National Stock Exchange of India

Market data

Live price

Current market quote for this ticker.

Current price

NSE/MEDPLUS

In the news

Latest news · NSE/MEDPLUS

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E44.4

P25 24.9P50 32.4P75 45.7

Trailing P/E50.7

P25 24.8P50 35.9P75 56.9

ROEn/a

P25 6.3P50 13.6P75 18.1

ROIC10.1

P25 4.1P50 10.3P75 17.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All NSE/MEDPLUS market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

176

Groups with data

Currency

INR

Showing 176 of 176 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	India
Country code	IN
Employees	25,007
Employees Change	1,592%
Employees Change Percent	6.8
Enterprise value	INR 111.9B
Exchange	National Stock Exchange of India
Financial currency	INR
First seen	2026-05-10
Industry	Pharmaceutical Retailers
Isin	INE804L01022
Last refreshed	2026-05-10
Market cap	INR 105B
Price	INR 874
Price currency	INR
Rev Per Employee	2,614,343.98x
Sector	Healthcare
Sic	5912
Symbol	nse/MEDPLUS
Website	https://www.medplusindia.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	1.97%
EV Earnings	54.07x
EV/EBIT	35.37x
EV/EBITDA	19.69x
EV/Sales	1.71x
Forward P/E	44.37x
P/B ratio	5.69x
P/E ratio	50.72x
P/S ratio	1.61x
PE Ratio3 Y	104.35x
PE Ratio5 Y	122.02x
PEG ratio	1.93x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	4.84%
EBITDA Margin	6.05%
Gross margin	25.86%
Gross Profit	INR 16.9B
Gross Profit Growth	19.71%
Gross Profit Growth Q	20.87%
Gross Profit Growth3 Y	22.87%
Gross Profit Growth5 Y	26.24%
Net Income	INR 2.1B
Net Income Growth	56.37%
Net Income Growth Q	25.98%
Net Income Growth Quarters	12%
Net Income Growth Years	2%
Net Income Growth3 Y	81%
Net Income Growth5 Y	148.6%
Pretax Margin	3.92%
Profit Margin	3.17%
Profit Per Employee	INR 82,777
Profitable Years	7
Roa5y	4.18
Roe5y	7.12
ROIC	10.08
Roic5y	6.91

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	5.2%
Cagr3y	6.72%
EPS Growth	56.41
EPS Growth Q	25.92
EPS Growth Quarters	12
EPS Growth Years	2
EPS Growth3 Y	75.92
EPS Growth5 Y	143.4
Revenue Growth	6.88x
Revenue Growth Q	15.67x
Revenue Growth Quarters	23x
Revenue Growth Years	6x
Revenue Growth3 Y	15.25x
Revenue Growth5 Y	17.89x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Cash	INR 5B
Debt	INR 11.9B
Debt EBITDA	INR 2.1
Debt Equity	INR 0.65
Equity	INR 18.4B
Interest Coverage	2.78
Net Cash	INR -6.9B
Net Cash By Market Cap	INR -6.58
Net Debt EBITDA	INR 1.75
Net Debt Equity	INR 0.37
Tangible Book Value	INR 17.9B
Tangible Book Value Per Share	INR 150
WACC	6.75

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.01%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	5.19%
200-day SMA	826.8
3Y total return	21.55%
50-day SMA	851.4
50-day SMA vs 200-day SMA	50over200
All Time High	1,343
All Time High Change	-34.91%
All Time High Date	2022-01-20
All Time Low	548.3
All Time Low Change	59.43%
All Time Low Date	2022-12-01
ATR	24.83
Beta	0.43
Beta1y	0.09
Beta2y	-0.14
Ch YTD	8.27
High	880.9
High52	1,045.3
High52 Date	2025-05-28
High52ch	-16.38%
Low	863.7
Low52	732
Low52 Date	2025-10-03
Low52ch	19.41%
Ma50ch	2.67%
Price vs 200-day SMA	5.72%
RSI	52.51
RSI Monthly	55.68
RSI Weekly	56.49
Sharpe ratio	0.31x
Sortino ratio	0.72
Total Return	0.01%
Tr YTD	8.27
Tr1m	3.66%
Tr1w	0.53%
Tr3m	0.6%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	INR 3.2B
Operating Income Growth	41.17
Operating Income Growth Q	22.58
Operating Income Growth3 Y	54.29
Operating Income Growth5 Y	26.73
Operating margin	4.84

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	69,670,363%
Shares Insiders	13.29%
Shares Institutions	38.31%
Shares Out	120,054,642
Shares Qo Q	0.04%
Shares Yo Y	-0.01%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	132,777.85x
Bv Per Share	153.9
Ch1m	3.66
Ch1w	0.53
Ch1y	5.19
Ch3m	0.6
Ch3y	21.55
Ch6m	11.02
Change	-0.84%
Change From Open	-0.77
Close	881.5
Days Gap	-0.07
Depreciation Amortization	792,072,500
Dollar Volume	43,070,403.4
Earnings Date	2026-05-20
EBIT	INR 3.2B
EBITDA	INR 4B
EPS	INR 17.24
F Score	2
Fiscal Year End	March
Founded	2,006
Graham Number	244.37179
Graham Upside	-72.04
Income Tax	INR 491.5M
Is Primary Listing	1
Last Earnings Date	2026-01-30
Last Report Date	2025-12-31
Lynch Fair Value	INR 431
Lynch Upside	-50.68
Ma150	818
Ma150ch	6.86%
Ma20	877.8
Ma20ch	-0.42%
Next Earnings Date	2026-05-20
Open	880.9
Position In Range	60.76
Price Date	2026-05-08
Price EBITDA	INR 26.54
Ptbv Ratio	5.85
Relative Volume	0.34x
Revenue	65,376,900,000x
Tax By Revenue	0.75x
Tax Rate	19.19%
Tr6m	11.02%
Volume	49,274

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does NSE/MEDPLUS pay a dividend?

Capital-return profile for this ticker.

Performance

NSE/MEDPLUS stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns NSE/MEDPLUS?

Insider, institutional, and short-interest positioning.

Institutional ownership

+38.3%

Share of float held by funds and institutions

Insider ownership

+13.3%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-0.0%

Negative means the company is buying back shares.

Technical

NSE/MEDPLUS momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

52.5

Neutral momentum band

Price vs 200-day MA

+5.7%

50/200-day relationship not available

Beta (5Y)

0.43

Less volatile than the market

Sharpe ratio

0.31

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About NSE/MEDPLUS

Hub-level FAQ points readers to the deeper analysis pages.

What is the current nse/MEDPLUS stock rating?

nse/MEDPLUS is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full nse/MEDPLUS analysis?

The full report lives at /stocks/nse/MEDPLUS/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for nse/MEDPLUS?

The latest report frames nse/MEDPLUS around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the nse/MEDPLUS page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.